Scandium Canada is trading 6.67% down at CA$0.14, with no clearly established catalyst for the decline. - Supplied price context shows a decline from the October 29 close of CA$0.15; no reliable October 30 volume figure was available. - No newly reported company announcement dated October 30 surfaced. The latest releases identified were dated October 21 and October 14. - The October 14 release described a potential new zone, with assay results pending; it does not explain the decline.